Immunoreactive trypsin on dried-blood spots as a possible neonatal test for cystic fibrosis

1980 ◽  
Vol 10 (3) ◽  
pp. 511-519 ◽  
Author(s):  
Roberto Dominici ◽  
Fabrizio Monaco ◽  
Silvana Morano ◽  
Italo Antonozzi
1981 ◽  
Vol 113 (2) ◽  
pp. 111-121 ◽  
Author(s):  
Jeanette R. Crossley ◽  
Patricia A. Smith ◽  
Brian W. Edgar ◽  
Peter D. Gluckman ◽  
Robert B. Elliott

2020 ◽  
Vol 6 (1) ◽  
pp. 8 ◽  
Author(s):  
Georges Travert ◽  
Mary Heeley ◽  
Anthony Heeley

This review summarises the trajectory of neonatal screening strategies for the detection of cystic fibrosis (CF) using the measurement of Immunoreactive Trypsin (IRT) in dried blood spots (DBS) from 1979 until the beginning of the 21st century when newborn screening (NBS) programmes started to spread throughout many countries, using IRT measurement combined with a CF genotype analysis of DBS.


1990 ◽  
Vol 23 (3) ◽  
pp. 213-219 ◽  
Author(s):  
Giulio Cabrini ◽  
Fabio Pederzini ◽  
Laura Perobelli ◽  
Gianni Mastella

1981 ◽  
Vol 27 (5) ◽  
pp. 678-680 ◽  
Author(s):  
L T Kirby ◽  
D A Applegarth ◽  
A G Davidson ◽  
L T Wong ◽  
D F Hardwick

Abstract We assayed more than 5000 blood spots dried on filter paper and approximately 1000 serum samples for immunoreactive trypsin, with commercial reagents (Behring and Sorin). The assay procedures were modified so that newborn screening is technically feasible. Both kits are satisfactory for serum assay, but the Sorin materials are better adapted for blood spot analysis. Immunoreactive trypsin in blood spots rapidly decreases with specimen age, but is stable in frozen serum. Values for premature infants do not differ significantly from those for full-term babies. Children with cystic fibrosis were readily distinguished from those without, up to at least one year of age.


1991 ◽  
Vol 143 (1) ◽  
pp. 69-72 ◽  
Author(s):  
S.M. Cordon ◽  
J.S. Elborn ◽  
E.J. Hiller ◽  
D.J. Shale

Sign in / Sign up

Export Citation Format

Share Document